Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01270958Phase 4Completed
A Phase 4 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by GSK. Started Aug 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01270958.